InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
0.845
+0.025 (3.02%)
Mar 9, 2026, 4:00 PM EDT - Market closed
InterCure Employees
InterCure had 320 employees as of December 31, 2024. The number of employees increased by 50 or 18.52% compared to the previous year.
Employees
320
Change (1Y)
50
Growth (1Y)
18.52%
Revenue / Employee
$225,495
Profits / Employee
-$65,789
Market Cap
47.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zhengye Biotechnology Holding | 277 |
| Rockwell Medical | 244 |
| Cumberland Pharmaceuticals | 91 |
| Aytu BioPharma | 83 |
| Assertio Holdings | 58 |
| BioXcel Therapeutics | 37 |
| SCYNEXIS | 28 |
| Talphera | 13 |
INCR News
- 18 days ago - InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million - GlobeNewsWire
- 4 months ago - InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation - GlobeNewsWire
- 5 months ago - InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow - GlobeNewsWire
- 6 months ago - InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands - GlobeNewsWire
- 11 months ago - InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025 - PRNewsWire
- 1 year ago - InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak - PRNewsWire
- 1 year ago - InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - PRNewsWire
- 1 year ago - Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga